This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatic Fibrosis or Hepatocellular Carcinoma
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine: - The efficacy of MRE score as a predictor of HCC recurrence within 2 years after RFA treatment - The efficacy of each indicator (MRE score, non-invasive serum markers) compared to the gold-standard histology score predicting hepatic fibrosis

Provided treatments

  • Procedure: Magnetic resonance elastography

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01447667. The sponsor of the trial is Seoul National University Hospital and it is looking for 72 volunteers for the current phase.
Official trial title:
Magnetic Resonance Elastography Score Reflecting Hepatic Fibrosis as an Independent Predictor for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy